Eureka Home »
Welcome to Eureka, an online community for scientists to explore, connect and share big ideas.
A 2014 survey found only 53 percent of Americans were confident that vaccines are safe and effective. That's half the population in a country which, 50 years ago, lined up in droves for a polio shot. What's going on?
Microsampling has become one of the big discussion points in animal research, but we have a long way to go before the technique is routine. Here are five points you may not know with respect to liquid microsampling.
Scientists began developing syngeneic models over 50 years ago. Researchers are now "profiling" as many of these syngeneic cell lines as possible in hopes of steering research questions to the right model.
After years of debate, the FDA is poised to approve its first biosimilar. Charles River biologics experts talk about they think is likely—and not likely—to happen next.
President Obama's proposed US$3.9 trillion budget, unveiled earlier today, reflects a 6% increase in research and development spending.
R&D Magazine highlights PCR methods being used to improve the health of animal research colonies.
Scientists, laboratory animal research community members, advocates, and educators can play important roles in advancing public dialogue beyond old and polarized scripts.
Seven tips for ensuring a reliable, reproducible immunopotency assay in vaccine testing
How a young chemist's first discovery project helped bring a new cancer drug to market.
Morphological and functional imaging methods are becoming an integral part of the drug development as early and translational biomarkers in drug discovery and safety assessment.